Dataset Information

Exome-wide analysis of mutational burden in patients with typical and atypical Rolandic epilepsy.

ABSTRACT: Rolandic epilepsy (RE) is the most common focal epilepsy in childhood. To date no hypothesis-free exome-wide mutational screen has been conducted for RE and atypical RE (ARE). Here we report on whole-exome sequencing of 194 unrelated patients with RE/ARE and 567 ethnically matched population controls. We identified an exome-wide significantly enriched burden for deleterious and loss-of-function variants only for the established RE/ARE gene GRIN2A. The statistical significance of the enrichment disappeared after removing ARE patients. For several disease-related gene-sets, an odds ratio >1 was detected for loss-of-function variants.

SUBMITTER: Bobbili DR

PROVIDER: S-EPMC5839048 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Exome-wide analysis of mutational burden in patients with typical and atypical Rolandic epilepsy.

Bobbili Dheeraj R DR Lal Dennis D May Patrick P Reinthaler Eva M EM Jabbari Kamel K Thiele Holger H Nothnagel Michael M Jurkowski Wiktor W Feucht Martha M Nürnberg Peter P Lerche Holger H Zimprich Fritz F Krause Roland R Neubauer Bernd A BA Reinthaler Eva M EM Zimprich Fritz F Feucht Martha M Steinböck Hannelore H Neophytou Birgit B Geldner Julia J Gruber-Sedlmayr Ursula U Haberlandt Edda E Ronen Gabriel M GM Altmüller Janine J Lal Dennis D Nürnberg Peter P Sander Thomas T Thiele Holger H Krause Roland R May Patrick P Balling Rudi R Lerche Holger H Neubauer Bernd A BA

European journal of human genetics : EJHG 20180122 2

Rolandic epilepsy (RE) is the most common focal epilepsy in childhood. To date no hypothesis-free exome-wide mutational screen has been conducted for RE and atypical RE (ARE). Here we report on whole-exome sequencing of 194 unrelated patients with RE/ARE and 567 ethnically matched population controls. We identified an exome-wide significantly enriched burden for deleterious and loss-of-function variants only for the established RE/ARE gene GRIN2A. The statistical significance of the enrichment d ...[more]

PMID: 29358611

Similar Datasets

Project description:Autophagy degrades and recycles intracellular components to sustain metabolism and survival during starvation. Tumor cells upregulate and require autophagy to support their metabolism and enhance their proliferation and malignancy, and host autophagy also promotes tumor growth by providing essential tumor nutrients such as arginine in the circulation or alanine in the local tumor microenvironment. In addition to its metabolic role, autophagy regulates immune cell homeostasis and function, and suppresses inflammation, which may also play a role in cancer. Although host autophagy does not promote a T cell anti-tumor immune response in tumors with low tumor mutational burden (TMB), whether this was the case in tumors with high TMB was not known. Here we show that in contrast to low TMB tumors, host-specific deletion of the essential autophagy gene Atg7 induces a pro-inflammatory cytokine response and limits the growth of high TMB tumors, which is rescued by T-cell depletion. Expression of immune-related genes is increased in tumors from Atg7Δ/Δ hosts in a T-cell dependent manner. Tumors from Atg7Δ/Δ hosts also have decreased T regulatory cells (Tregs), and depletion of Tregs phenocopies the reduced tumor growth observed in Atg7Δ/Δ hosts. Moreover, loss of Stimulator of interferon genes (Sting) or IFNg restores growth of high TMB tumors on Atg7Δ/Δ hosts. Finally, similar to whole-body loss of autophagy, specific loss of autophagy in the liver is sufficient to limit tumor growth. Thus, autophagy, especially in the liver, promotes tumor immune tolerance by limiting STING, T cells, and IFNg, which enables tumor growth. We have designated this: Hepatic Autophagy Immune Tolerance (HAIT). Autophagy thereby promotes tumor growth through both metabolic and immune mechanisms depending on mutational load, and autophagy inhibition is an effective means to promote an anti-tumor T-cell response in high TMB tumors. Genomic DNA Profiling using Agilent SureSelect Mouse All Exon kit and sequencing using Illumina NextSeq550

Dataset Information

Exome-wide analysis of mutational burden in patients with typical and atypical Rolandic epilepsy.

Publications

Exome-wide analysis of mutational burden in patients with typical and atypical Rolandic epilepsy.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure